NEW YORK, NY / ACCESSWIRE / March 22, 2016 / Despite the challenges that continue to press the Biotech industry, ValuableInvestment.com, this morning, turns its focus on the following Healthcare companies: Celgene Corp. (NASDAQ: CELG), Ariad Pharmaceuticals Inc. (NASDAQ: ARIA), Exelixis Inc. (NASDAQ: EXEL), and Chimerix Inc. (NASDAQ: CMRX). Find out why these stocks are under our microscope by clicking the link below:
http://valuableinvestment.com/tradesecrets
Celgene Corp.'s stock climbed 2.41% to finish Monday's trading session at $101.14. A total volume of 5.67 million shares was traded. The Company’s shares are trading below their 50-day moving average by 1.35%. The stock has a Relative Strength Index (RSI) of 49.04. Sign up and get the alert on CELG at:
http://valuableinvestment.com/CELG
At the closing bell yesterday, shares in Ariad Pharmaceuticals Inc. ended 3.19% higher at $6.47, and with a total volume of 2.29 million shares traded. The stock has advanced 26.37% in the last one month, 3.85% over the previous three months, and 3.52% on an YTD basis. The Company's shares are trading above their 50-day moving average by 18.42%. Furthermore, shares of Ariad Pharmaceuticals have an RSI of 60.65. The complete trade setup on ARIA is available for free at:
http://valuableinvestment.com/ARIA
On Monday, shares in Exelixis Inc. recorded a trading volume of 4.53 million shares, and ended the session with a slight correction of 0.26% at $3.86. The stock is trading 8.35% below its 50-day moving average. The Company's shares have an RSI of 46.73. The complimentary alert on EXEL can be activated at:
http://valuableinvestment.com/EXEL
Shares in Chimerix Inc. closed the day at $5.15 with a slight correction of 1.15%. The stock recorded a trading volume of 1.57 million shares. The Company's shares are trading 22.35% below their 50-day moving average. Additionally, Chimerix's stock has an RSI of 40.78. Register for free on ValuableInvestment.com and access the latest strategies on CMRX at:
http://valuableinvestment.com/CMRX
--
About ValuableInvestment.com:
Valuable Investment was founded in 2006 and has been successfully alerting investors and shareholders of the most profitable ways to earn a living on Wall Street. A decade is a very long time so we must be doing something right. We encourage everyone to come and try our strategy and see how we have been changing the foundation of research for years.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.
NO WARRANTY
ValuableInvestment.com, the Author, the Reviewer, and the Sponsor (collectively referred to as the "Publishers') are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither valuableinvestment.com nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To read our disclosures, or for more information, visit http://valuableinvestment.com/
RESTRICTIONS
ValuableInvestment.com is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press@valuableinvestment.com
SOURCE: ValuableInvestment.com
